Nova Leap is an acquisitive home health care services company operating in one of the fastest-growing industries in the U.S. & Canada. The company performs a vital role within the continuum of care with an individual and family centered focus, particularly those requiring dementia care. Nova Leap achieved the #42 ranking on the 2021 Report on Business ranking of Canada’s Top Growing Companies, the #2 ranking on the 2020 Report on Business ranking of Canada’s Top Growing Companies and the #10 ranking in the 2019 TSX Venture 50™ in the Clean Technology & Life Sciences sector. The Company is geographically diversified with operations in 10 different U.S. states within the New England, Southeastern, South Central and Midwest regions as well as in Nova Scotia, Canada.
Nova Leap is a public company trading on the TSX Venture Exchange (TSXV: NLH). The company has reported consecutive quarters of record results. Nova Leap is focused on the private pay sector of home care and has expanded significantly the past few years with revenue increasing from approximately $40,000 in 2016 to $28 million in 2022. Annualized Adjusted EBITDA based on Q3 figures is approximately $1.8 million and the Company does not have any long-term debt.
Nova Leap is one of the many featured companies slated to present at The Microcap Conference 2024, set for Jan. 30-Feb. 1 at Caesars Atlantic City Hotel and Casino. This three-day conference presented by DealFlow Events features technical programming designed for microcap investors and a presenting company track for pitching and socializing.
History of the company
“I founded the company in 2016 after seeing the benefits of home care that were provided to my father-in law the last couple years of his life as he lived with Parkinson’s disease,” said President and CEO Chris Dobbin. “Our company was created to assemble a portfolio of Home and Home Health Care companies that have the potential to be leaders in their particular market, particularly around dementia care.”
It is Nova Leap’s intention to continue growing through a combination of acquisitions and organic growth with a focus on North American companies.
Key personnel
As the founding President & CEO, Dobbin is responsible for the company’s strategy and results. He is joined on the Board by five independent directors who have a combination of home care, home health care, entrepreneurship, executive and public company experience.
Chris LeBlanc, Nova Leap’s CFO, will be presenting at the Microcap Conference 2024.
The company’s day-to-day operations in the U.S. and Canada are led by experienced health care personnel.
Looking to the future
“Our focus continues to be building from our record results by increasing EBITDA from existing operations while making further acquisitions,” Dobbin said. Learn more.
Tickets to the inaugural Microcap Conference 2024 are going fast. Reserve your seat now for three days of unsurpassed networking and technical discussions of the microcap sector with some of the best names in the business – institutional investors, finance-focused law firms, venture and private equity fund managers, deal advisors, PIPE funds, brokerage firms, investor relations professionals, accredited retail investors and many more. The conference schedule is also packed with entertainment and exciting activities set against the backdrop of Atlantic City’s bright lights.
Sponsored content, this is a paid promotion
Comments and opinions presented in DealFlow Events publications such as The Microcap Newsletter are solely those of the analysts, corporate executives, and others quoted. They do not represent the opinions of DealFlow Events and DealFlow Events makes no recommendations on whether to buy, sell or hold shares of any particular stock. Investors are advised to conduct their own research before making an investment decision. Neither DealFlow Events nor any of its affiliates hold any position in the stocks mentioned in The Microcap Newsletter.
